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activity (14.4±0.9 nmol/min.mg protein) sustained by reversed
electron ﬂow of the respiratory chain when succinate and ATP were
added. This activity was inhibited by the addition of rotenone (88%),
oligomycin (98%), antimycin (77%) andm-CCCP (93%). NO generation
by ETPH-Mg2+ resulted 0.62±0.03 nmol/min.mg protein in optimal
experimental conditions (0.5 mM MgCl2, 0.3 mM KCN). The mtNOS
activity was still detectable (99%) in the absence of an exogenous
electron donor (NADPH) suggesting that NO production could be
supported by electrons derived from the respiratory chain. Rotenone
inhibited mtNOS activity (86%) supported by reversed electron ﬂow,
but it did not inhibit the activity of isolated nNOS indicating that its
inhibitory effect on NO production by ETPH-Mg2+ is due to an
electron ﬂow inhibition and not to a direct action on mtNOS
structure. The dependence of mtNOS activity on metabolic state and
membrane potential, and the physical interaction among mtNOS,
cytochrome oxidase and complex I proteins, support the hypothesis
that mtNOS could interact with complex I proteins using electrons
derived from the respiratory chain for its enzymatic activity.
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Inhibition of the mitochondrial permeability transition pore (PTP)
has proved to be an effective strategy for preventing oxidative stress-
induced cell death, and the pore represents a viable cellular target for
drugs. Here, we report that inhibition of complex I by rotenone is
more effective at PTP inhibition than cyclosporin A (CsA) in tissues
that express low levels of the CsA mitochondrial target, cyclophilin D
(CypD); and, conversely, that tissues in which rotenone does not
affect the PTP are characterized by high levels of expression of CypD
and sensitivity to CsA. Consistent with a regulatory role of complex I
in the PTP-inhibiting effects of rotenone, the concentrations of the
latter required for PTP inhibition precisely match those required to
inhibit respiration; and a similar effect is seen with the antidiabetic
drug metformin, which partially inhibits complex I. Remarkably (i)
genetic ablation of CypD or its displacement with CsA restored PTP
inhibition by rotenone in tissues that are otherwise resistant to its
effects; and (ii) rotenone did not inhibit the PTP unless phosphate
was present, in striking analogy with the phosphate requirement for
the inhibitory effects of CsA. These results indicate that inhibition of
complex I by rotenone or metformin and displacement of CypD by
CsA affect the PTP through a common mechanism; and that cells can
modulate their PTP response to complex I inhibition by modifying the
expression of CypD, a ﬁnding that has major implications for pore
modulation in vivo.
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SERPINB3 (SB3) is a member of the family of ov-serin-protease
inhibitors overexpressed in epithelial and hepatic tumors. We have
found that a fraction of SB3 is located inmitochondria of hepatoma cells.
In order to understand whether the mitochondrial location of SB3 is
somehow connected to biological traits relevant to the neoplastic
phenotype, we have addressed the possibility that SB3 is part of the
anti-apoptotic machinery that hallmarks most tumor types. In partic-
ular, inhibition of the mitochondrial permeability transition pore (PTP)
constitutes a point of no-return in cell commitment to death, and its
inhibition is believed to play a primary role in tumor cell survival and
resistance to anticancer drugs.
We have found that stable transfection with either the human
wild type SB3 or the protease-dead DH-SB3 confers protection to
death induced in hepatoma cells either with the ﬁrst-line chemo-
therapeutic Cisplatin or with the PTP inducer EM20-25. Treatment
with the antioxidant compound N-acetyl cysteine could abrogate
death induction, and SB3-expressing cells show lower ROS levels both
in basal conditions and after EM20-25 treatment. Notably, we observe
that SB3 co-immunoprecipitates with respiratory chain Complex I,
one of the major sites of superoxide production in cells, and that this
interaction results in inhibition of Complex I activity.
Taken together, these results indicate that SB3 protects hepatoma
cells from death induced by oxidative stress through down-modulation
of Complex I and the ensuing PTP desensitization, paving the way for
the identiﬁcation of novel anti-neoplastic strategies.
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Endometrial carcinoma (EC) is a common neoplasia of the female
genital tract. This cancer may be grouped into two subsets, namely
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endometrioid endometrial carcinoma (type I, estrogen dependent)
and non-endometrioid carcinoma (type II, estrogen independent).
Type I is the most common form, developing usually from hyperplasia
and displaying a less aggressive behaviour than type II EC. An increase
of mitochondrial biogenesis and an up-regulation of the factors
involved in the PGC-1a-dependent mitochondrial biogenesis pathway
in type I EC compared to control endometrium have been reported by
our group [1]. Furthermore, we found in 69% of analyzed cancer
endometrial samples, tumor speciﬁc mitochondrial DNA (mtDNA)
mutations. In correlation with the occurrence of pathogenic tumor
speciﬁc mtDNA mutations, an increase of mitochondrial biogenesis
and an activation of antioxidant stress response mechanisms were
found in tumor tissues [2]. To verify whether the increase of
mitochondrial biogenesis might be the effect of a compensatory
response to respiratory chain deﬁciency due to pathogenic mtDNA
mutations, we investigated the assembly and the activity of some
respiratory chain complexes (I and IV) in control and type I EC
samples with or without tumor speciﬁc mtDNA mutations in these
two complexes. Immunoblot analysis after nondenaturing Blue
Native Gel Electrophoresis (BN-PAGE) of the respiratory complexes
revealed a reduction of assembled complex I in tumor samples with
mtDNA mutations in complex I subunits. This deﬁciency of complex I
was also conﬁrmed by in-gel activity assays. No reduction of complex
IV was found, conﬁning the damage speciﬁcally to complex I.
Our data indicate that in type I EC the increase of mitochondrial
biogenesis might be the effect of a compensatory response to
complex I deﬁciency due to mtDNA mutations.
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NADH:ubiquinone oxidoreductase, also known as respiratory
complex I, plays a central role in cellular energy production by
coupling the electron transfer from NADH to ubiquinone with proton
translocation across the membrane. Complex I from Escherichia
coli consists of 13 subunits and 10 co factors, including 9 iron–sulfur
(Fe/S) clusters [1]. Almost nothing is known about its assembly, though
it is very likely that such a complex machinery assembles gradually by
joining prefabricated assembly intermediates. These intermediates are
assembled to the entire complex with the help of chaperons. A possible
candidate for a chaperone involved in assembly of Fe/S clusters is YajL,
the E. coli homolog of Parkinsonism-associated protein DJ-1. It was
shown that YajL covalently binds to NuoG by formation of mixed
disulﬁdes and that the d-NADH:DCPIP activity of the ΔyajL mutant is
signiﬁcantly decreased upon oxidative stress [2]. It is therefore
possible that YajL plays an important role in keeping NuoG in an
assembly competent state during insertion of Fe/S clusters. We have
investigated whether the lack of YajL inhibits the assembly of
complex I and characterized the effect of the deletion on the
formation of Fe/S clusters. The role of YajL for the assembly of E. coli
complex I is discussed.
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Respiratory complex I is a key player in the energy transduction
process in cell mitochondria, providing circa 40% of the proton
translocation required for the biosynthesis of ATP. This membrane
protein complex (with approximately 1 MDa) catalyzes the oxidation
of NADH and the reduction of quinone, coupled to ion translocation
across the membrane. Complex I has an L-shape structure with two
main domains: the membrane embedded and the hydrophilic
domain. The membrane domain holds the ion translocation machin-
ery and is proposed to sense conformational changes of the
hydrophilic domain where the electron transfer from NADH to
quinone occurs through several redox cofactors. The membrane arm
has a curved shape with a total length of 180 Å and is constituted by
seven subunits (NuoA, H, J, K, L, M and N). NuoLMN are the
antiporter-like subunits responsible for ion transport.
NuoH is proposed to be the transmembrane subunit connecting
the peripheral arm and the membrane embedded domain. Despite
the high resolution structures available for Complex I, structural
information regarding the NuoH subunit is only available at low
resolution. Due to its localization, NuoH is expected to play a key role
in transmitting the information to the three antiporter-like subunits.
Using a bioinformatics approach we identiﬁed a sequence and
structural link between NuoH and the antiporter-like subunits from
complex I. To further investigate this possibility we combined
bioinformatics analysis and homology modelling to obtain a homol-
ogy model of NuoH from E. coli. Our results suggest that NuoH subunit
is structurally related to the antiporter-like subunits of complex I.
These ﬁndings support the existence of an evolutionary link between
NuoH and the antiporter-like subunits of complex I (NuoL/M/N).
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